EROP-RC (NEoadjuvant Radiotherapy for Older Patients ? Rectal Cancer): a randomised controlled phase III study

South City Hospital Rostock (Klinikum Suedstadt Rostock) (Germany)0 个研究点目标入组 800 人开始时间: 2012年10月16日最近更新: 2017年4月24日

适应症

试验速览

暂无简介。

•1. Patients with primary diagnosis of histologically bioptically secured diagnosis of rectal cancer
•2. Rectal cancer at any height (up to 16cm lower edge of tumor measured from the anal line using inflexible rectoscopy)
•3. Decision made by the treating tumor team that intensified RCT is not possible
•4. Preoperative tumor staging max. uT1-4uN1-2M0
•5. Age >/= 70 years
•6. Karnofsky index >/= 70%
•7. ASA-classification < IV
•8. Oral and written consent according to
•9. Good Clinical Practice and corresponding local, national and international regulations

•1. Other previous cancer illnesses with the exception of appropriately treated in situ carcinoma of the cervix or skin tumors with no indication of melanoma or in cases of tumor-free state = 10 years subsequent to appearance of cancer which has undergone appropriate treatment
•2. Participation in studies elsewhere which include chemotherapy or radiotherapy
•3. Inability to participate in regular check-ups

发起方

South City Hospital Rostock (Klinikum Suedstadt Rostock) (Germany)